Tech Company Financing Transactions
Tesseract Health Funding Round
Foresite Capital, Glenview Capital Management and Opaleye Management invested in a $80 million Series B capital raise for Tesseract Health. The round was announced on 4/21/2021.
Transaction Overview
Company Name
Announced On
4/21/2021
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series B
Investors
Proceeds Purpose
The funds will be used to conduct research to advance the Tesseract iC platform, accelerate the company's push to obtain US and international regulatory clearances, and ramp up manufacturing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
530 Old Whitfield Rd.
Guilford, CT 06437
USA
Guilford, CT 06437
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
The eye is the window into the body. Tesseract is building a portable, affordable device for monitoring and preventing disease. 4Catalyzer is founded by Jonathan Rothberg, the inventor of Next-Gen DNA sequencing and ultrasound-on-a-chip (Butterfly Network).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Jonathan Rothberg
Browse more venture capital transactions:
Prev: 4/21/2021: Teal Communications venture capital transaction
Next: 4/21/2021: Alto Solutions venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs